David Watkins is a Pathology professor at George Washington University. He is a fellow in the American Academy of Microbiology and recipient of the Elizabeth Glaser Scientist Award, a prestigious accolade for scientists advancing research to eradicate pediatric AIDS.

David’s research currently focuses on developing monoclonal antibodies (mAbs) against infectious disease, specifically to prevent and treat yellow fever, dengue, Zika, Covid-19, and other viruses from the betacoronavirus family.

He has authored 225 peer-reviewed publications in top-ranked journals and is a former faculty member at  Harvard University, the University of Wisconsin, and the University of Miami.

David earned his B.Sc. in Botany & Zoology from the University of Durham, and both his M.Sc. and Ph.D in Immunology from the University of Rochester.

David Watkins is a Pathology professor at George Washington University. He is a fellow in the American Academy of Microbiology and recipient of the Elizabeth Glaser Scientist Award, a prestigious accolade for scientists advancing research to eradicate pediatric AIDS.

David’s research currently focuses on developing monoclonal antibodies (mAbs) against infectious disease, specifically to prevent and treat yellow fever, dengue, Zika, Covid-19, and other viruses from the betacoronavirus family.

He has authored 225 peer-reviewed publications in top-ranked journals and is a former faculty member at  Harvard University, the University of Wisconsin, and the University of Miami.

David earned his B.Sc. in Botany & Zoology from the University of Durham, and both his M.Sc. and Ph.D in Immunology from the University of Rochester.